BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 10618369)

  • 1. Structural interactions of fibroblast growth factor receptor with its ligands.
    Stauber DJ; DiGabriele AD; Hendrickson WA
    Proc Natl Acad Sci U S A; 2000 Jan; 97(1):49-54. PubMed ID: 10618369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin.
    Pellegrini L; Burke DF; von Delft F; Mulloy B; Blundell TL
    Nature; 2000 Oct; 407(6807):1029-34. PubMed ID: 11069186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A dimeric ternary complex of FGFR [correction of FGFR1], heparin and FGF-1 leads to an 'electrostatic sandwich' model for heparin binding.
    Huhtala MT; Pentikäinen OT; Johnson MS
    Structure; 1999 Jun; 7(6):699-709. PubMed ID: 10404599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structures of two FGF-FGFR complexes reveal the determinants of ligand-receptor specificity.
    Plotnikov AN; Hubbard SR; Schlessinger J; Mohammadi M
    Cell; 2000 May; 101(4):413-24. PubMed ID: 10830168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis for activation of fibroblast growth factor signaling by sucrose octasulfate.
    Yeh BK; Eliseenkova AV; Plotnikov AN; Green D; Pinnell J; Polat T; Gritli-Linde A; Linhardt RJ; Mohammadi M
    Mol Cell Biol; 2002 Oct; 22(20):7184-92. PubMed ID: 12242295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetic model for FGF, FGFR, and proteoglycan signal transduction complex assembly.
    Ibrahimi OA; Zhang F; Hrstka SC; Mohammadi M; Linhardt RJ
    Biochemistry; 2004 Apr; 43(16):4724-30. PubMed ID: 15096041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular characteristics of fibroblast growth factor-fibroblast growth factor receptor-heparin-like glycosaminoglycan complex.
    Venkataraman G; Raman R; Sasisekharan V; Sasisekharan R
    Proc Natl Acad Sci U S A; 1999 Mar; 96(7):3658-63. PubMed ID: 10097093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis for FGF receptor dimerization and activation.
    Plotnikov AN; Schlessinger J; Hubbard SR; Mohammadi M
    Cell; 1999 Sep; 98(5):641-50. PubMed ID: 10490103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequence analyses and comparative modeling of fly and worm fibroblast growth factor receptors indicate that the determinants for FGF and heparin binding are retained in evolution.
    Nagendra HG; Harrington AE; Harmer NJ; Pellegrini L; Blundell TL; Burke DF
    FEBS Lett; 2001 Jul; 501(1):51-8. PubMed ID: 11457455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of receptor and heparin binding sites in fibroblast growth factor 4 by structure-based mutagenesis.
    Bellosta P; Iwahori A; Plotnikov AN; Eliseenkova AV; Basilico C; Mohammadi M
    Mol Cell Biol; 2001 Sep; 21(17):5946-57. PubMed ID: 11486033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of heparan sulfate in fibroblast growth factor signalling: a structural view.
    Pellegrini L
    Curr Opin Struct Biol; 2001 Oct; 11(5):629-34. PubMed ID: 11785766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Common and specific determinants for fibroblast growth factors in the ectodomain of the receptor kinase complex.
    Wang F; Lu W; McKeehan K; Mohamedali K; Gabriel JL; Kan M; McKeehan WL
    Biochemistry; 1999 Jan; 38(1):160-71. PubMed ID: 9890894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of mutations in fibroblast growth factor (FGF) and a pathogenic mutation in FGF receptor (FGFR) provides direct evidence for the symmetric two-end model for FGFR dimerization.
    Ibrahimi OA; Yeh BK; Eliseenkova AV; Zhang F; Olsen SK; Igarashi M; Aaronson SA; Linhardt RJ; Mohammadi M
    Mol Cell Biol; 2005 Jan; 25(2):671-84. PubMed ID: 15632068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of heparin saccharides on the formation of specific fibroblast growth factor (FGF) and FGF receptor complexes.
    Ostrovsky O; Berman B; Gallagher J; Mulloy B; Fernig DG; Delehedde M; Ron D
    J Biol Chem; 2002 Jan; 277(4):2444-53. PubMed ID: 11714710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel type I fibroblast growth factor receptor activates mitogenic signaling in the absence of detectable tyrosine phosphorylation of FRS2.
    Lopez ME; Korc M
    J Biol Chem; 2000 May; 275(21):15933-9. PubMed ID: 10748122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparan sulfate fibroblast growth factor receptor complex: structure-function relationships.
    McKeehan WL; Kan M
    Mol Reprod Dev; 1994 Sep; 39(1):69-81; discusison 81-2. PubMed ID: 7999363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of residues important both for primary receptor binding and specificity in fibroblast growth factor-7.
    Sher I; Lang T; Lubinsky-Mink S; Kuhn J; Adir N; Chatterjee S; Schomburg D; Ron D
    J Biol Chem; 2000 Nov; 275(45):34881-6. PubMed ID: 10950949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural basis for fibroblast growth factor receptor activation.
    Mohammadi M; Olsen SK; Ibrahimi OA
    Cytokine Growth Factor Rev; 2005 Apr; 16(2):107-37. PubMed ID: 15863029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selectively desulfated heparin inhibits fibroblast growth factor-induced mitogenicity and angiogenesis.
    Lundin L; Larsson H; Kreuger J; Kanda S; Lindahl U; Salmivirta M; Claesson-Welsh L
    J Biol Chem; 2000 Aug; 275(32):24653-60. PubMed ID: 10816596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis for fibroblast growth factor receptor 2 activation in Apert syndrome.
    Ibrahimi OA; Eliseenkova AV; Plotnikov AN; Yu K; Ornitz DM; Mohammadi M
    Proc Natl Acad Sci U S A; 2001 Jun; 98(13):7182-7. PubMed ID: 11390973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.